Cargando…

Near Infrared Imaging of EGFR of Oral Squamous Cell Carcinoma in Mice Administered Arsenic Trioxide

BACKGROUND: The effectiveness of near-infrared imaging (NIR) interrogation of epidermal growth factor receptor (EGFR) expression as a sensitive biomarker of oral squamous cell carcinoma (OSCC) response to arsenic trioxide therapy was studied in mice. MATERIAL AND METHODS: A431 OSCC in vitro were exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lingbo, Wang, Kezheng, Zhao, Falin, Hu, Weiping, Chen, Junjie, Lanza, Gregory M., Shen, Baozhong, Zhang, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460885/ https://www.ncbi.nlm.nih.gov/pubmed/23029451 http://dx.doi.org/10.1371/journal.pone.0046255

Ejemplares similares

In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice
por: Yang, Kai, et al.
Publicado: (2011)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
por: Li, Yacong, et al.
Publicado: (2022)

Arsenic Trioxide Triggers Apoptosis of Metastatic Oral Squamous Cells Carcinoma with Concomitant Downregulation of GLI1 in Hedgehog Signaling
por: Nogueira, Raphael Luís Rocha, et al.
Publicado: (2022)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017)

Surface Passivation of Carbon Nanoparticles with Branched Macromolecules Influences Near Infrared Bioimaging
por: Wu, Lina, et al.
Publicado: (2013)

Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020)

Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis
por: Au, Wing-Yan, et al.
Publicado: (2012)

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Immunological consequences of arsenic trioxide-induced necrosis
por: Gavali, Shubhangi, et al.
Publicado: (2023)

Retracted: Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Medicine, Evidence-Based Complementary and Alternative
Publicado: (2021)

The Protective Role of Resveratrol against Arsenic Trioxide-Induced Cardiotoxicity
por: Zhang, Weiqian, et al.
Publicado: (2013)

Protective effect of resveratrol on arsenic trioxide-induced nephrotoxicity in rats
por: Zhang, Weiqian, et al.
Publicado: (2014)

The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases
por: Chin, Lynn, et al.
Publicado: (2022)

Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
por: Varghese, Mathews V., et al.
Publicado: (2013)

Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2015)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol
por: Mondal, Bodhisattwa, et al.
Publicado: (2018)

QT Independent Ventricular Tachycardia Induced by Arsenic Trioxide
por: Zeitjian, Vicken, et al.
Publicado: (2019)

Establishment and characterization of arsenic trioxide resistant KB/ATO cells
por: Zhang, Yun-Kai, et al.
Publicado: (2017)

Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis
por: Zhang, Yong, et al.
Publicado: (2016)

Arsenic trioxide as a novel anti-glioma drug: a review
por: Fang, Yi, et al.
Publicado: (2020)

Arsenic trioxide-induced apoptosis contributes to suppression of viral reservoir in SIV-infected rhesus macaques
por: He, Yizi, et al.
Publicado: (2023)

Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disorders
por: Ravandi, Farhad, et al.
Publicado: (2020)

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
por: Kumana, Cyrus R., et al.
Publicado: (2022)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

Arsenic Trioxide Promotes Tumor Progression by Inducing the Formation of PGCCs and Embryonic Hemoglobin in Colon Cancer Cells
por: Li, Zugui, et al.
Publicado: (2021)

Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy
por: Yu, Mengzhen, et al.
Publicado: (2022)

Dual effects of arsenic trioxide on tumor cells and the potential underlying mechanisms
por: Zhang, Xiao, et al.
Publicado: (2018)

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
por: Zheng, Yu, et al.
Publicado: (2021)

Ameliorative effects and mechanism of crocetin in arsenic trioxide-induced cardiotoxicity in rats
por: Zhao, Zhifeng, et al.
Publicado: (2020)

Honokiol attenuate the arsenic trioxide‐induced cardiotoxicity by reducing the myocardial apoptosis
por: Huang, An‐Liang, et al.
Publicado: (2022)

Preliminary experimental study on carcinogenicity of arsenic trioxide in rat lung.
por: Ishinishi, N, et al.
Publicado: (1977)

Mortality experience in relation to a measured arsenic trioxide exposure
por: Pinto, Sherman S., et al.
Publicado: (1977)

Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide
por: Sertel, Serkan, et al.
Publicado: (2012)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
por: Sun, Ramon C, et al.
Publicado: (2011)

Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes
por: Udensi, Udensi K, et al.
Publicado: (2011)

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
por: Li, Ning, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p2amm1ktjr79i7hpr5snb00gan